DM
Drugs Made In America Acquisition Corp. Units
DMAAU · NASDAQ
$10.99 +0.00% (+$0.00)
1M +1.56%
Market Cap $257.5M
P/E Ratio 42.25x
Div. Yield -
ROE 3.53%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/E 42.25x
EV/EBITDA N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
37 /100
Average ROE 3.53%
Asset turnover 0.00x
ROA 4.15%
Debt
0 /100
High Current ratio 0.02x
Debt/Equity N/A
Debt/Assets N/A
Stability
0 /100
Unstable Beta 0.19x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o DMAAU
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Roger Bendelac
Employees
2
Headquarters
New York